-
1
-
-
0344961471
-
The partial thromboplastin time (cephalin time) in anticoagulant therapy
-
Struver GP, Bittner DL. The partial thromboplastin time (cephalin time) in anticoagulant therapy. Am J Clin Pathol 1962;38: 473-81.
-
(1962)
Am J Clin Pathol
, vol.38
, pp. 473-481
-
-
Struver, G.P.1
Bittner, D.L.2
-
2
-
-
0024416374
-
A comparison of two APTT reagents which use silica activators
-
Ray MJ, Hawson GAT. A comparison of two APTT reagents which use silica activators. Clin Lab Haematol 1989;11:221-32.
-
(1989)
Clin Lab Haematol
, vol.11
, pp. 221-232
-
-
Ray, M.J.1
Hawson, G.A.T.2
-
4
-
-
0028567316
-
Activated partial thromboplastin time for automated techniques: A comparison of two commonly used reagents
-
Craig S, Stevenson KJ, Taberner DA. Activated partial thromboplastin time for automated techniques: a comparison of two commonly used reagents. Br J Biomed Sci 1994;51:321-7.
-
(1994)
Br J Biomed Sci
, vol.51
, pp. 321-327
-
-
Craig, S.1
Stevenson, K.J.2
Taberner, D.A.3
-
5
-
-
0030014877
-
The therapeutic range for heparin therapy: Relationship between six activated partial thromboplastin time reagents and two heparin assays
-
Kitchen S, Preston FE. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays. Thromb Haemost 1996;75: 734-9.
-
(1996)
Thromb Haemost
, vol.75
, pp. 734-739
-
-
Kitchen, S.1
Preston, F.E.2
-
6
-
-
51849182567
-
Use of the activated partial thromboplastin time for monitoring heparin therapy: Problems and possible solutions
-
Poller L, Thomson JM, Taberner DA. Use of the activated partial thromboplastin time for monitoring heparin therapy: problems and possible solutions. Res Clin Lab 1989;19:363-70.
-
(1989)
Res Clin Lab
, vol.19
, pp. 363-370
-
-
Poller, L.1
Thomson, J.M.2
Taberner, D.A.3
-
7
-
-
0027092654
-
An attempt to standardize APTT reagents used to monitor heparin therapy
-
Ray M, Carroll P, Smith I, Hawson G. An attempt to standardize APTT reagents used to monitor heparin therapy. Blood Coag Fibrinol 1992;3:743-8.
-
(1992)
Blood Coag Fibrinol
, vol.3
, pp. 743-748
-
-
Ray, M.1
Carroll, P.2
Smith, I.3
Hawson, G.4
-
8
-
-
0028356281
-
An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study
-
Reed SV, Haddon ME, Denson KWE. An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study. Thromb Res 1994;74: 515-22.
-
(1994)
Thromb Res
, vol.74
, pp. 515-522
-
-
Reed, S.V.1
Haddon, M.E.2
Denson, K.W.E.3
-
9
-
-
0028878422
-
The APTT monitoring of heparin - The ISTH/ICSH collaborative study
-
Van der Velde EA, Poller L. The APTT monitoring of heparin - the ISTH/ICSH collaborative study. Thromb Haemost 1995;73:73-81.
-
(1995)
Thromb Haemost
, vol.73
, pp. 73-81
-
-
Van Der Velde, E.A.1
Poller, L.2
-
10
-
-
0030057043
-
Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage
-
Kitchen S, Jennings I, Woods TAL, Preston FE. Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage. J Clin Pathol 1996;49:10-4.
-
(1996)
J Clin Pathol
, vol.49
, pp. 10-14
-
-
Kitchen, S.1
Jennings, I.2
Woods, T.A.L.3
Preston, F.E.4
-
11
-
-
0027732256
-
Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin
-
Van den Besselaar AMHP, Neuteboom J, Bertina RM. Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin. Blood Coag Fibrinol 1993;4:895-903.
-
(1993)
Blood Coag Fibrinol
, vol.4
, pp. 895-903
-
-
Van Den Besselaar, A.M.H.P.1
Neuteboom, J.2
Bertina, R.M.3
-
12
-
-
0028210230
-
Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids
-
Bader R, Mannucci PM, Tripodi A, Hirsh J, Keller F, Solleder EM, et al. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemost 1994;71:292-9.
-
(1994)
Thromb Haemost
, vol.71
, pp. 292-299
-
-
Bader, R.1
Mannucci, P.M.2
Tripodi, A.3
Hirsh, J.4
Keller, F.5
Solleder, E.M.6
-
13
-
-
0018835636
-
Heparin and partial thromboplastin time: An international survey
-
Poller L, Thomson JM, Yee KF. Heparin and partial thromboplastin time: an international survey. Br J Haematol 1980;44:161-5.
-
(1980)
Br J Haematol
, vol.44
, pp. 161-165
-
-
Poller, L.1
Thomson, J.M.2
Yee, K.F.3
-
14
-
-
0020027425
-
Preparation of a stable phospholipid reagent for coagulation assays
-
Barrowcliffe TW, Stocks J, Gray E. Preparation of a stable phospholipid reagent for coagulation assays. Haemostasis 1982;11: 96-101.
-
(1982)
Haemostasis
, vol.11
, pp. 96-101
-
-
Barrowcliffe, T.W.1
Stocks, J.2
Gray, E.3
-
15
-
-
0027209887
-
Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing
-
Van den Besselaar AMHP, Meeuwisse-Braun J. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing. Blood Coag Fibrinol 1993;4: 635-8.
-
(1993)
Blood Coag Fibrinol
, vol.4
, pp. 635-638
-
-
Van Den Besselaar, A.M.H.P.1
Meeuwisse-Braun, J.2
-
16
-
-
0025174959
-
Monitoring heparin therapy: Relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples
-
Van den Besselaar AMHP, Meeuwisse-Braun J, Bertina RM. Monitoring heparin therapy: relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples. Thromb Haemost 1990;63:16-23.
-
(1990)
Thromb Haemost
, vol.63
, pp. 16-23
-
-
Van Den Besselaar, A.M.H.P.1
Meeuwisse-Braun, J.2
Bertina, R.M.3
-
17
-
-
8544224663
-
Use of synthetic phospholipids in an APTT reagent for monitoring treatment with heparin
-
Neuteboom J, Van den Besselaar AMHP, Bertina RM. Use of synthetic phospholipids in an APTT reagent for monitoring treatment with heparin [Abstract]. Thromb Haemost 1991;65: 906.
-
(1991)
Thromb Haemost
, vol.65
, pp. 906
-
-
Neuteboom, J.1
Van Den Besselaar, A.M.H.P.2
Bertina, R.M.3
-
18
-
-
73049137829
-
The effect of colloidal silica on blood coagulation
-
Margolis J. The effect of colloidal silica on blood coagulation. Aust J Exp Biol 1961;39:249-58.
-
(1961)
Aust J Exp Biol
, vol.39
, pp. 249-258
-
-
Margolis, J.1
-
19
-
-
0022639295
-
Partial thromboplastin time test - Proposed performance guidelines
-
Koepke JA. Partial thromboplastin time test - proposed performance guidelines. Thromb Haemost 1986;55:143-4.
-
(1986)
Thromb Haemost
, vol.55
, pp. 143-144
-
-
Koepke, J.A.1
-
20
-
-
0013632115
-
The activated partial thromboplastin time
-
Thomson JM, ed. Edinburgh: Churchill Livingstone
-
Thomson JM, Poller L. The activated partial thromboplastin time. In: Thomson JM, ed. Blood coagulation and haemostasis, a practical guide. Edinburgh: Churchill Livingstone, 1985;301-39.
-
(1985)
Blood Coagulation and Haemostasis, a Practical Guide
, pp. 301-339
-
-
Thomson, J.M.1
Poller, L.2
-
21
-
-
0026055774
-
One-step chromogenic equivalent of activated partial thromboplastin time evaluated for clinical application
-
Ponjee GAE, Vader HL, de Wild PJ, Janssen GWT, van der Graaf F. One-step chromogenic equivalent of activated partial thromboplastin time evaluated for clinical application. Clin Chem 1991; 37:1235-44.
-
(1991)
Clin Chem
, vol.37
, pp. 1235-1244
-
-
Ponjee, G.A.E.1
Vader, H.L.2
De Wild, P.J.3
Janssen, G.W.T.4
Van Der Graaf, F.5
-
22
-
-
0024449513
-
Randomized study of adjusted versus fixed-dose heparin prophylaxis of deep vein thrombosis in hip surgery
-
Taberner DA, Poller L, Thomson JM, Lemon G, Weighill FJ. Randomized study of adjusted versus fixed-dose heparin prophylaxis of deep vein thrombosis in hip surgery. Br J Surg 1989;76: 933-5.
-
(1989)
Br J Surg
, vol.76
, pp. 933-935
-
-
Taberner, D.A.1
Poller, L.2
Thomson, J.M.3
Lemon, G.4
Weighill, F.J.5
-
23
-
-
0020501831
-
Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement
-
Leyvraz PF, Richard J, Bachmann F, Van Melle G, Treyvard J, Livio J. Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 1983;309:954-8.
-
(1983)
N Engl J Med
, vol.309
, pp. 954-958
-
-
Leyvraz, P.F.1
Richard, J.2
Bachmann, F.3
Van Melle, G.4
Treyvard, J.5
Livio, J.6
-
24
-
-
0023003183
-
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis
-
Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 1986;315:1109-14.
-
(1986)
N Engl J Med
, vol.315
, pp. 1109-1114
-
-
Hull, R.D.1
Raskob, G.E.2
Hirsh, J.3
Jay, R.M.4
Leclerc, J.R.5
Geerts, W.H.6
-
25
-
-
0025009152
-
Subcutaneous vs intravenous heparin in the treatment of deep-venous thrombosis. A randomized clinical trial
-
Pini M, Pattacini C, Quintavalla R, Poli T, Megha A, Tagliaferri A, et al. Subcutaneous vs intravenous heparin in the treatment of deep-venous thrombosis. A randomized clinical trial. Thromb Haemost 1990;64:222-6.
-
(1990)
Thromb Haemost
, vol.64
, pp. 222-226
-
-
Pini, M.1
Pattacini, C.2
Quintavalla, R.3
Poli, T.4
Megha, A.5
Tagliaferri, A.6
-
26
-
-
0028118694
-
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin
-
Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, et al. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 1994;154:49-56.
-
(1994)
Arch Intern Med
, vol.154
, pp. 49-56
-
-
Levine, M.N.1
Hirsh, J.2
Gent, M.3
Turpie, A.G.4
Cruickshank, M.5
Weitz, J.6
-
27
-
-
0021189964
-
The antithrombotic effect of heparin in deep venous thrombosis: Relation to four heparin assays
-
Holm HA, Abildgaard U, Kalvenes S, Anderssen N, Anker E, Arnesen KE, et al. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays. Acta Med Scand 1984;216:287-93.
-
(1984)
Acta Med Scand
, vol.216
, pp. 287-293
-
-
Holm, H.A.1
Abildgaard, U.2
Kalvenes, S.3
Anderssen, N.4
Anker, E.5
Arnesen, K.E.6
-
28
-
-
0021880148
-
Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding
-
Holm HA, Abildgaard U, Kalvenes S. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding. Thromb Haemost 1985;53:278-81.
-
(1985)
Thromb Haemost
, vol.53
, pp. 278-281
-
-
Holm, H.A.1
Abildgaard, U.2
Kalvenes, S.3
-
29
-
-
0028848160
-
Response of the activated partial thromboplastin time (APTT) to heparin is influenced by coagulometers
-
Van den Besselaar AMHP, Meeuwisse-Braun J, Strebus A, Schaefer-Van Mansfeld H, Witteveen E, Van der Meer FJM. Response of the activated partial thromboplastin time (APTT) to heparin is influenced by coagulometers. Thromb Haemost 1995; 74:1383-4.
-
(1995)
Thromb Haemost
, vol.74
, pp. 1383-1384
-
-
Van Den Besselaar, A.M.H.P.1
Meeuwisse-Braun, J.2
Strebus, A.3
Schaefer-Van Mansfeld, H.4
Witteveen, E.5
Van Der Meer, F.J.M.6
|